BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9767885)

  • 1. [Pregnancy in a patient treated with trientine dihydrochloride for Wilson's disease].
    Desbriere R; Roquelaure B; Sarles J; Boubli L
    Presse Med; 1998 May 2-9; 27(17):806. PubMed ID: 9767885
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of treatment of Wilson's disease on natural history of haemochromatosis.
    Walshe JM; Cox DW
    Lancet; 1998 Jul; 352(9122):112-3. PubMed ID: 9672279
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B; Chung SJ; Shin HW
    J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease treated with trientine during pregnancy.
    Devesa R; Alvarez A; de las Heras G; Ramón de Miguel J
    J Pediatr Gastroenterol Nutr; 1995 Jan; 20(1):102-3. PubMed ID: 7884606
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
    Deguchi K; Sasaki I; Touge T; Tsukaguchi M; Ikeda K; Shimamura M; Urai Y; Watanabe S; Takeuchi H; Kuriyama S
    J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pregnancy, labor and early puerperium in a patient with Wilson's disease].
    Hlinst'ák K; Borovský M; Hlinst'áková S
    Ceska Gynekol; 1999 Jun; 64(3):198-200. PubMed ID: 10568054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease and pregnancy.
    Sternlieb I
    Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
    [No Abstract]   [Full Text] [Related]  

  • 10. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment.
    Chung EJ; Kim EG; Kim SJ; Ji KH; Seo JH
    Neurocase; 2016; 22(1):40-4. PubMed ID: 25988284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson's disease--treatment of psychiatric manifestations in pregnancy.
    Rich AM; Lajoie TM
    Psychosomatics; 2012; 53(2):175-7. PubMed ID: 22424165
    [No Abstract]   [Full Text] [Related]  

  • 13. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].
    Serra B; Primo J; García M; Amorós I; Aragó M; Merino C
    Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilson's disease in pregnancy.
    Nunns D; Hawthorne B; Goulding P; Maresh M
    Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):141-3. PubMed ID: 7493698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of psychiatric symptoms in Wilson's disease: treatment and prognostic considerations.
    Zimbrean PC; Schilsky ML
    Am J Psychiatry; 2015 Nov; 172(11):1068-72. PubMed ID: 26575449
    [No Abstract]   [Full Text] [Related]  

  • 17. Triethylene-tetramine (trien) therapy for Wilson's disease.
    Saito H; Watanabe K; Sahara M; Mochizuki R; Edo K; Ohyama Y
    Tohoku J Exp Med; 1991 May; 164(1):29-35. PubMed ID: 1926144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
    Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
    Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition, diagnosis, and management of Wilson's disease.
    Brewer GJ
    Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ; Chen C; You ZF; Yang RM; Wang XP
    Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.